Literature DB >> 10690693

Contribution of adverse drug reactions to hospital admission of older patients.

C K Mannesse1, F H Derkx, M A de Ridder, A J Man in 't Veld, T J van der Cammen.   

Abstract

OBJECTIVE: To describe the severity of adverse drug reactions as a factor in hospital admission of older patients, and to identify risk indicators for severe adverse drug reactions in these patients.
DESIGN: Observational cross-sectional study.
SETTING: Five wards in a university hospital in The Netherlands.
SUBJECTS: Patients aged 70 and over admitted to general medical wards.
METHODS: Use of statistical comparison and Kramer's algorithm.
RESULTS: A severe adverse drug reaction was present in 25 (24%) of 106 patients. Thirteen patients (12%; 95% confidence interval 6.1-18.6%) were admitted probably because of an adverse drug reaction. Risk indicators for a severe adverse drug reaction were a fall before admission (odds ratio 51.3, P = 0.006), gastrointestinal bleeding or haematuria (odds ratio 19.8, P < 0.001) and the use of three or more drugs (odds ratio 9.8, P = 0.04).
CONCLUSION: Adverse drug reactions are an important cause of hospital admissions in older people. A fall before admission may indicate a severe adverse drug reaction.

Entities:  

Mesh:

Year:  2000        PMID: 10690693     DOI: 10.1093/ageing/29.1.35

Source DB:  PubMed          Journal:  Age Ageing        ISSN: 0002-0729            Impact factor:   10.668


  82 in total

1.  Multidisciplinary medication review in nursing home residents: what are the most significant drug-related problems? The Bergen District Nursing Home (BEDNURS) study.

Authors:  S Ruths; J Straand; H A Nygaard
Journal:  Qual Saf Health Care       Date:  2003-06

2.  Prevalence of potentially preventable unplanned hospitalizations caused by therapeutic failures and adverse drug withdrawal events among older veterans.

Authors:  Zachary A Marcum; Mary Jo V Pugh; Megan E Amuan; Sherrie L Aspinall; Steven M Handler; Christine M Ruby; Joseph T Hanlon
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-03-01       Impact factor: 6.053

Review 3.  The role of the pharmacist in optimizing pharmacotherapy in older people.

Authors:  Anne Spinewine; Daniela Fialová; Stephen Byrne
Journal:  Drugs Aging       Date:  2012-06-01       Impact factor: 3.923

Review 4.  Adverse drug reactions in older people: detection and prevention.

Authors:  Mirko Petrovic; Tischa van der Cammen; Graziano Onder
Journal:  Drugs Aging       Date:  2012-06-01       Impact factor: 3.923

5.  Adverse drug reactions leading to urgent hospital admission in an elderly population: prevalence and main features.

Authors:  Consuelo Pedrós; Francesc Formiga; Xavier Corbella; Josep Maria Arnau
Journal:  Eur J Clin Pharmacol       Date:  2015-11-07       Impact factor: 2.953

6.  Usually Available Clinical and Laboratory Data Are Insufficient for a Valid Medication Review: A Crossover Study.

Authors:  K P G M Hurkens; C Mestres-Gonzalvo; H A J M de Wit; P H M van der Kuy; R Janknegt; F Verhey; J M G A Schols; C D A Stehouwer; B Winkens; W Mulder
Journal:  J Nutr Health Aging       Date:  2016-01       Impact factor: 4.075

7.  Detection of adverse drug reactions in a neurological department: comparison between intensified surveillance and a computer-assisted approach.

Authors:  Petra A Thuermann; Roland Windecker; Joachim Steffen; Markus Schaefer; Ute Tenter; Erich Reese; Hermann Menger; Klaus Schmitt
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

8.  Mortality among patients due to adverse drug reactions that lead to hospitalization: a meta-analysis.

Authors:  Tejas K Patel; Parvati B Patel
Journal:  Eur J Clin Pharmacol       Date:  2018-03-19       Impact factor: 2.953

9.  NSAID and aspirin use by the elderly in general practice: effect on gastrointestinal symptoms and therapies.

Authors:  Alberto Pilotto; Marilisa Franceschi; Gioacchino Leandro; Francesco Di Mario
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

10.  Regional surveillance of emergency-department visits for outpatient adverse drug events.

Authors:  A Capuano; A Irpino; M Gallo; L Ferrante; M L Illiano; B Rinaldi; A Filippelli; F Rossi
Journal:  Eur J Clin Pharmacol       Date:  2009-03-18       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.